交控科技(688015.SH):7月15日至12月20日累計獲得政府補助2504.74萬元
格隆匯12月21日丨交控科技(688015.SH)公佈,公司全資子公司深圳交控科技有限公司(簡稱“深圳交控”)、天津交控科技有限公司(簡稱“天津交控”)、成都交控科技有限公司(簡稱“成都交控”)、重慶交控科技有限公司(簡稱“重慶交控”)、交控技術裝備有限公司(簡稱“交控裝備”)以及控股子公司北京大象科技有限公司(簡稱“大象科技”)、內蒙古交控安捷科技有限公司(簡稱“內蒙古安捷”)、北京埃福瑞科技有限公司(簡稱“埃福瑞”)、廣西交控智維科技發展有限公司(簡稱“廣西交控智維”)自2021年7月15日至2021年12月20日,累計獲得政府補助款項人民2504.74萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.